Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Destructive vs. Non-Destructive Testing – V 2.0

Posted on By

Elixir Department: SOP for Destructive vs. Non-Destructive Testing – V 2.0

Standard Operating Procedure for Destructive and Non-Destructive Testing of Elixir Products

Department Elixir Department
SOP No. SOP/ELX/240/2025
Supersedes SOP/ELX/240/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for distinguishing and conducting destructive and non-destructive tests on elixir formulations during in-process, finished product, and stability testing phases.

2. Scope

This SOP applies to the Quality Control Department and applies to all batches of elixirs where physical, chemical, or microbiological evaluations require either destructive or non-destructive approaches.

3. Responsibilities

  • QC Analyst:
    • Perform assigned tests based on defined method classification (destructive/non-destructive).
  • QC Supervisor:
    • Review test plans and ensure sample integrity based on test classification.
  • QA Officer:
    • Review test execution strategy and approve method suitability.

4. Accountability

The QC Head is accountable for implementation and adherence to this SOP. The QA Head is responsible for ensuring that sample classification aligns with regulatory expectations and internal policies.

See also  Elixir Department: SOP for Compressed Air System in Mixing Units - V 2.0

5. Procedure

5.1 Definitions

  • Destructive Testing: Testing in which the sample is altered, destroyed,
or rendered unusable post-evaluation.
  • Non-Destructive Testing: Testing in which the sample remains intact and suitable for retention or further use.
  • 5.2 Examples of Destructive Testing

    • Assay of active ingredients by HPLC
    • Preservative content and alcohol content tests
    • Microbial limit testing
    • pH testing requiring container opening

    5.3 Examples of Non-Destructive Testing

    • Visual inspection for clarity, color, and particulate matter
    • Container integrity testing (e.g., vacuum leak detection, torque testing)
    • Labeling, packaging, and fill volume inspection (external only)

    5.4 Sample Management

    1. Segregate samples for destructive vs. non-destructive tests before initiating testing.
    2. Label containers appropriately with “Destructive” or “Non-Destructive”.
    3. Record the batch number, container number, and purpose of test in the Sample Management Log (Annexure-1).

    5.5 Testing and Reporting

    1. Conduct tests as per the validated methods and document findings.
    2. Destructive test samples must not be returned to inventory or reused.
    3. Non-destructive test samples must be retained and handled per SOP for retained samples, if required.
    4. Record results separately for each test type in respective data sheets or LIMS systems.

    5.6 Disposal of Destructive Samples

    1. Destroy samples post-testing in accordance with waste disposal SOP.
    2. Document disposal details in the Sample Disposal Log with QA review.

    5.7 Auditing and Review

    1. QA shall review classification of test types periodically.
    2. Any reclassification of a method must be updated in the master method list.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    • LIMS: Laboratory Information Management System

    7. Documents

    1. Sample Management Log (Annexure-1)
    2. Sample Disposal Log
    3. Master Test Method List

    8. References

    • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
    • WHO Technical Report Series 996 – Annex 2
    • 21 CFR Part 211 – Subpart I: Laboratory Controls

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Sample Management Log

    Date Batch No. Container ID Test Type Analyst Disposition
    11/04/2025 ELX-0425-056 CN-015 Destructive Rajesh Kumar Disposed after assay
    11/04/2025 ELX-0425-056 CN-016 Non-Destructive Sunita Reddy Retained in stability chamber

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP Creation QA Head
    11/04/2025 2.0 Clarified classification and added control checks Regulatory Compliance QA Head
    See also  Elixir Department: SOP for Cleaning During Campaign Manufacturing - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: SOP for Qualification of HPLC System – V 2.0
    Next Post: Analytical Method Development: SOP for Qualification of UV-Visible Spectrophotometer – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version